Clinical Trials Logo

Filter by:
NCT ID: NCT03909932 Completed - Clothing Clinical Trials

How to Dress up in Neuro-urology Department

Start date: April 10, 2019
Phase:
Study type: Observational

This study assess patient preferences and perceptions regarding physician dress code in a neuro-urology department.

NCT ID: NCT03911427 Completed - Clinical trials for Elevated LDL Cholesterol

Oat and Cholesterol

Start date: April 10, 2019
Phase: N/A
Study type: Interventional

The primary objective is to assess the effect of an oat ingredient provided over 4 weeks on serum LDL cholesterol in men and women with elevated LDL-cholesterol compared to a placebo. Secondary endpoints are fasting serum total- and HDL-cholesterol, non-HDL-cholesterol, triglycerides, glucose, insulin, glycated albumin, HOMA-IR and Framingham risk score

NCT ID: NCT03918187 Completed - Clinical trials for Cesarean Section Pain

Intrathecal Nalbuphine Versus Midazolam in Cesarean Section

Start date: April 10, 2019
Phase: Phase 1
Study type: Interventional

Adequate pain management is important to facilitate the functional recovery and enable the patients for rapid rehabilitation of normal activity . Various adjuvants were being used with intrathecal bupivacain to prolong & improve postoperative pain relief in patients undergoing cesarean section . The aim of this study was to compare intrathecal nalbuphine versus intrathecal midazolam in patient undergoing cesarean section. The investigators primary aims were to compare the characteristics of sensory and motor block, the effective analgesic time, and analgesic requirement. Secondary aims were to compare the side effects, sedation score and apgare score.

NCT ID: NCT03920592 Completed - Bullying of Child Clinical Trials

Virtual Reality and Prevention of Bullying

Start date: April 10, 2019
Phase: N/A
Study type: Interventional

The lack of empathy towards victims of bullying is thought to play a main role in this extended and pernicious peer victimization behaviour. Thus, promoting empathy in school programs might be a promising approach for bullying prevention. Virtual reality (VR) allows creating an environment very similar to the real world and has proved to promote empathy. Therefore, by employing VR, pupils may better understand and feel the experience of being bullied. As there is no evidence of the efficiency of VR in bullying prevention, the first step is to validate the content of the environments created. In this line, the current study aims to investigate if 360º-videos produce a truthful experience of being bullied superior than the observed in traditional computer screens. The effect of all, 360º-videos and 2D computer screens will be assessed through objective (electrodermal activity -EDA- and heart rate -HR-) and subjective (self-administered tests) measures.

NCT ID: NCT03921541 Completed - Hyperargininemia Clinical Trials

Efficacy and Safety of Pegzilarginase in Patients With Arginase 1 Deficiency

Start date: April 10, 2019
Phase: Phase 3
Study type: Interventional

CAEB1102-300A is a multi-center randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of pegzilarginase in patients with ARG1-D. This study will consist of a screening period; a randomized, double-blind treatment period; a long-term extension; and a follow up visit for final safety assessments.

NCT ID: NCT03924427 Completed - Psoriasis Clinical Trials

An Investigational Study to Evaluate Experimental Medication BMS-986165 in Japanese Participants With Moderate-to-Severe Psoriasis

Start date: April 10, 2019
Phase: Phase 3
Study type: Interventional

The purpose of this study is to investigate BMS-986165 given to Japanese participants with moderate-to-severe psoriasis.

NCT ID: NCT03927976 Completed - Clinical trials for Tobacco Use Cessation

Feasibility of a Culturally-Specific Video Text Cessation Intervention With AA Quitline Callers

Start date: April 10, 2019
Phase: N/A
Study type: Interventional

Assess the feasibility and acceptability of delivering an mHealth tobacco intervention among state quitline enrollees.

NCT ID: NCT03932344 Completed - Clinical trials for Still Disease, Juvenile Onset

Long-term Safety Study of Kineret® in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)

Start date: April 10, 2019
Phase:
Study type: Observational

The purpose of the study is to evaluate and characterize long-term safety of Kineret when used in standard clinical practice to treat patients with systemic juvenile idiopathic arthritis (SJIA). The study will be based on already available data from the Pharmachild juvenile idiopathic arthritis (JIA) registry which holds the European Network of Centers for Pharmacoepidemiology and Pharmacovigilance (ENCePP) study seal.

NCT ID: NCT03934398 Completed - Hypertension Clinical Trials

Be-HealthY: Behavioral Risk Factors for Poor Vascular Health in Youth

Start date: April 10, 2019
Phase:
Study type: Observational

The investigators aim to determine the association of dietary intake on cardiovascular disease risk factors among children with overweight and obesity who are being evaluated for elevated blood pressure. The investigators will also investigate for predictors of vascular function and determine if predictors vary by level of sodium intake.

NCT ID: NCT03934424 Completed - Appetitive Behavior Clinical Trials

Weight Stigma Effect on Neural Control of Appetite

Start date: April 10, 2019
Phase: N/A
Study type: Interventional

The limited data available suggest that exposure to weight-based stigmatization leads to overeating and increased desire for food. In the present study, overweight and obese individuals (BMI from 25-35 kg/m2) who are generally healthy will be randomized to read a weight-stigma article or control article and subsequently scanned to collect fMRI data. These procedures will be employed to accomplish two specific aims. Specific Aim 1: Determine the neural mechanisms involved in exposure to weight stigma on central control of appetite in overweight and obese individuals. To accomplish this aim we will collect fMRI data in study participants when viewing food and scenery pictures after being exposed to either a weight-stigma or control article. In addition, participants will complete validated questionnaires to measure perceived weight-stigma experiences and social support for eating and physical activity. Hypothesis: After reading an article depicting weight stigmatization, when shown pictures of food in the fMRI scanner, overweight/obese individuals that perceive themselves as having experienced higher levels of weight stigma and lower levels of social support, will have higher activations of brain regions that control appetite and food reward (amygdala, orbitofrontal cortex, striatum, insula) and reduced activations in brain areas that regulate self-control and decision making (prefrontal cortex and cingulate cortex respectively) compared to a control group that reads a non-weight stigma article. Specific Aim 2: To assess the relationship between activity in appetitive and self-control brain regions and self-reported, eating-related behavior. To accomplish this aim, participants will also complete questionnaires that measure self-reported food intake motivation (dietary restraint, disinhibition and hunger), appetitive responses, and mood. Hypothesis: Higher activations in appetite and reward regions and lower activations in self-control brain regions will be correlated with higher levels of dietary disinhibition, hunger/appetite, and dietary restraint.